These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 31654330)

  • 41. Reversible symptomatic biliary obstruction associated with ceftriaxone pseudolithiasis.
    Zinberg J; Chernaik R; Coman E; Rosenblatt R; Brandt LJ
    Am J Gastroenterol; 1991 Sep; 86(9):1251-4. PubMed ID: 1882806
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ceftriaxone-associated nephrolithiasis and biliary pseudolithiasis.
    de Moor RA; Egberts AC; Schröder CH
    Eur J Pediatr; 1999 Dec; 158(12):975-7. PubMed ID: 10592073
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Experimental verification of factors influencing calcium salt formation based on a survey of the development of ceftriaxone-induced gallstone-related disorder.
    Ito R; Yoshida A; Taguchi K; Enoki Y; Yokoyama Y; Matsumoto K
    J Infect Chemother; 2019 Dec; 25(12):972-978. PubMed ID: 31186195
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Disappearing "gallstones": biliary pseudolithiasis complicating ceftriaxone therapy.
    Kirejczyk WM; Crowe HM; Mackay IM; Quintiliani R; Cronin EB
    AJR Am J Roentgenol; 1992 Aug; 159(2):329-30. PubMed ID: 1632349
    [No Abstract]   [Full Text] [Related]  

  • 45. [Four cases of ceftriaxone-associated biliary pseudolithiasis].
    Niwa M; Tochii K
    Nihon Shokakibyo Gakkai Zasshi; 2016; 113(2):281-8. PubMed ID: 26853988
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endoscopic management of ceftriaxone pseudolithiasis involving the common bile duct and gallbladder.
    Lebovics E; Halata MS; Rosario JA; Lantin J; Schwarz SM; Rosenthal WS
    Gastrointest Endosc; 1994; 40(2 Pt 1):246-8. PubMed ID: 8013837
    [No Abstract]   [Full Text] [Related]  

  • 47. Early biliary pseudolithiasis during ceftriaxone therapy for acute pyelonephritis in children: a prospective study in 34 children.
    Bonnet JP; Abid L; Dabhar A; Lévy A; Soulier Y; Blangy S
    Eur J Pediatr Surg; 2000 Dec; 10(6):368-71. PubMed ID: 11215777
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ceftriaxone-associated biliary pseudolithiasis in children.
    Herek O; Pakdemirli E; Koçer N
    Eur Radiol; 2001; 11(5):902. PubMed ID: 11372630
    [No Abstract]   [Full Text] [Related]  

  • 49. Risk factors leading to ceftriaxone-associated biliary pseudolithiasis in children.
    Kong MS; Chen CY
    Changgeng Yi Xue Za Zhi; 1996 Mar; 19(1):50-4. PubMed ID: 8935375
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ceftriaxone-associated nephrolithiasis and biliary pseudolithiasis in a child.
    Prince JS; Senac MO
    Pediatr Radiol; 2003 Sep; 33(9):648-51. PubMed ID: 12830336
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Epigastric colic after ceftriaxone therapy].
    Sorantin E; Fotter R; Hausegger KA; Grubbauer HM
    Monatsschr Kinderheilkd; 1992 Aug; 140(8):488-9. PubMed ID: 1435809
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reversible ceftriaxone-associated biliary pseudolithiasis in children.
    Schaad UB; Wedgwood-Krucko J; Tschaeppeler H
    Lancet; 1988 Dec; 2(8625):1411-3. PubMed ID: 2904533
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Complications of ceftriaxone-associated biliary pseudolithiasis and neprolithiasis: a case report.
    Sienra MC; Pereira Núñez D; Pacheco H; Juambeltz C
    Cir Pediatr; 2020 Jul; 33(3):149-152. PubMed ID: 32657101
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increasing urinary calcium excretion after ceftriaxone and cephalothin therapy in adults: possible association with urolithiasis.
    Otunctemur A; Ozbek E; Polat EC; Cekmen M; Dursun M; Cakir SS
    Urolithiasis; 2014 Apr; 42(2):105-8. PubMed ID: 24310104
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biliary pseudolithiasis in a child associated with 2 days of ceftriaxone therapy.
    Blais C; Duperval R
    Pediatr Radiol; 1994; 24(3):218-9. PubMed ID: 7936805
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gall-bladder sludge: lessons from ceftriaxone.
    Kim YS; Kestell MF; Lee SP
    J Gastroenterol Hepatol; 1992; 7(6):618-21. PubMed ID: 1486190
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [CEFTRIAXONE-INDUCED GALLBADDER LITHIASIS IN CASE OF INTENSTINAL BACTERIAL INFECTIONS (CASE REPORTS)].
    Khotchava M; Lashkhi E; Jokhtaberidze T; Shalamberidze I
    Georgian Med News; 2016 Jan; (250):72-5. PubMed ID: 26870979
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ceftriaxone-associated biliary pseudolithiasis in adults.
    Pigrau C; Pahissa A; Gropper S; Sureda D; Martinez Vazquez JM
    Lancet; 1989 Jul; 2(8655):165. PubMed ID: 2567936
    [No Abstract]   [Full Text] [Related]  

  • 59. Acute necrotizing cholecystitis: a rare complication of ceftriaxone-associated pseudolithiasis.
    Kim S; Gura KM; Puder M
    Pediatr Surg Int; 2006 Jun; 22(6):562-4. PubMed ID: 16485100
    [No Abstract]   [Full Text] [Related]  

  • 60. A symptomatic child with ceftriaxone-associated biliary pseudolithiasis.
    Kutuya N; Ozaki Y; Okazaki T
    J Med Ultrason (2001); 2008 Sep; 35(3):125-8. PubMed ID: 27278835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.